Lanean...
Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy
Dimethyl fumarate (DMF) is one of the newer additions to the armamentarium of potent immunomodulators for the treatment of relapsing-remitting multiple sclerosis (RRMS). After more than 2 years of real-world experience and more than 190,000 patients currently treated with DMF worldwide, it is a good...
Gorde:
| Argitaratua izan da: | Ther Adv Chronic Dis |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935836/ https://ncbi.nlm.nih.gov/pubmed/27433310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316653307 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|